Should we view chronic obstructive pulmonary disease differently after ECLIPSE? A clinical perspective from the study team.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  American Journal of Respiratory and Critical Care Medicine

• Publication date

  2014-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1164/rccm.201311-2006PPPMID 24552242
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Persistent systemic inflammation and symptoms of depression among patients with COPD in the ECLIPSE cohort.

  2014cited by this paper
• Club cell protein 16 and disease progression in chronic obstructive pulmonary disease.

  2013cited by this paper
• Systemic soluble receptor for advanced glycation endproducts is a biomarker of emphysema and associated with AGER genetic variants in patients with chronic obstructive pulmonary disease.

  2013cited by this paper
• The COPD Biomarker Qualification Consortium (CBQC)

  2013cited by this paper
• The presence and progression of emphysema in COPD as determined by CT scanning and biomarker expression: a prospective analysis from the ECLIPSE study.

  2013cited by this paper
• Comorbidity, systemic inflammation and outcomes in the ECLIPSE cohort.

  2013cited by this paper
• Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.

  2013cited by this paper
• Soluble Receptor For Advanced Glycation Endproducts (sRAGE) Is A Biomarker Of Emphysema In The ECLIPSE Cohort

  2012cited by this paper
• Bronchodilator responsiveness as a phenotypic characteristic of established chronic obstructive pulmonary disease

  2012cited by this paper
• Annual change in pulmonary function and clinical phenotype in chronic obstructive pulmonary disease.

  2012cited by this paper
• Predicting outcomes from 6-minute walk distance in chronic obstructive pulmonary disease.

  2012cited by this paper
• Inflammatory biomarkers and comorbidities in chronic obstructive pulmonary disease.

  2012cited by this paper
• Inflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary disease.

  2012cited by this paper
• Factors influencing the decline in lung density in a Danish lung cancer screening cohort

  2012cited by this paper
• GOLD assessment of COPD patients: Impact of symptoms assessment choice

  2012cited by this paper
• The minimal clinically important difference (MCID) for the six minute walk (6MW) test in COPD in relation to death

  2012cited by this paper
• Coronary artery calcification in COPD is associated with adverse functional assessments and mortality

  2012cited by this paper
• Persistent Systemic Inflammation is Associated with Poor Clinical Outcomes in COPD: A Novel Phenotype

  2012cited by this paper
• Clinical impact of anaemia in patients with chronic obstructive pulmonary disease: Results from ECLIPSE study

  2012cited by this paper
• Quantifying the extent of emphysema: factors associated with radiologists' estimations and quantitative indices of emphysema severity using the ECLIPSE cohort.

  2011cited by this paper
• CT-quantified emphysema in male heavy smokers: association with lung function decline

  2011cited by this paper
• COPD association and repeatability of blood biomarkers in the ECLIPSE cohort

  2011cited by this paper
• Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort.

  2011cited by this paper
• Respiratory system impedance with impulse oscillometry in healthy and COPD subjects: ECLIPSE baseline results.

  2011cited by this paper
• The progression of chronic obstructive pulmonary disease is heterogeneous: the experience of the BODE cohort.

  2011cited by this paper
• Fatigue components in COPD patients and controls using the FACIT-F scale; data from ECLIPSE study

  2011cited by this paper
• Measurement Of Physical Activity In Patients With COPD In A Multicenter Setting: Compliance And Associations With Clinical Characteristics Of The Disease

  2011cited by this paper
• Reduced 6MWD Is Associated With Increased Mortality And Exacerbation-Related Hospitalization In COPD: The Eclipse Study

  2011cited by this paper
• One-Year Stability Of Quadriceps Muscle Strength In Patients With COPD: An Eclipse Sub Study

  2011cited by this paper
• Changes in forced expiratory volume in 1 second over time in COPD.

  2011cited by this paper
• Bias due to withdrawal in long‐term randomised trials in COPD: Evidence from the TORCH study

  2011cited by this paper
• Risk Factors And Mortality Associated With Hospitalized Chronic Obstructive Pulmonary Disease (COPD) Exacerbations During The 3-Year Follow-Up In The Evaluation Of COPD Longitudinally To Identify Predictive Surrogate Endpoints (Eclipse) Cohort

  2011cited by this paper
• Characterisation of COPD heterogeneity in the ECLIPSE cohort

  2010cited by this paper
• Chronic obstructive pulmonary disease phenotypes: the future of COPD.

  2010cited by this paper
• Susceptibility to exacerbation in chronic obstructive pulmonary disease.

  2010cited by this paper
• Frequent Chronic Obstructive Pulmonary Disease Exacerbators: How Much Real, How Much Fictitious?

  2010cited by this paper
• Chronic obstructive pulmonary disease biomarker(s) for disease activity needed--urgently.

  2010cited by this paper
• Determinants of poor 6-min walking distance in patients with COPD: the ECLIPSE cohort.

  2010cited by this paper
• Diagnosis of COPD Exacerbations and Their Distribution Based on GOLD Severity Stages. Data from the Evaluation of COPD Longitudinally To Identify Predictive Surrogate Endpoints (ECLIPSE) Study

  2009cited by this paper
• Derivation and validation of a composite index of severity in chronic obstructive pulmonary disease: the DOSE Index.

  2009cited by this paper
• Depression and its relationship with poor exercise capacity, BODE index and muscle wasting in COPD.

  2009cited by this paper
• P147 DISCRIMINATING EFFECTS OF MUSCLE WASTING WITH LOW AND NORMAL BMI IN COPD

  2009cited by this paper
• Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial.

  2009cited by this paper
• Exploring the role of CT densitometry: a randomised study of augmentation therapy in α1-antitrypsin deficiency

  2009cited by this paper
• Comparison of Perceived Exacerbation Frequency in COPD Patients and Actual Number of Exacerbations – Data from the ECLIPSE Study.

  2009cited by this paper
• Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index.

  2009cited by this paper
• Serum surfactant protein D is steroid sensitive and associated with exacerbations of COPD

  2009cited by this paper
• Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study

  2009cited by this paper
• Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE)

  2008cited by this paper
• Evaluation of serum CC-16 as a biomarker for COPD in the ECLIPSE cohort

  2008cited by this paper
• A 4-year trial of tiotropium in chronic obstructive pulmonary disease.

  2008cited by this paper
• Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study.

  2008cited by this paper
• Complex chronic comorbidities of COPD

  2008cited by this paper
• Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.

  2007cited by this paper
• Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life.

  2007cited by this paper
• Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease.

  2007cited by this paper
• Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.

  2007cited by this paper
• C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease.

  2007cited by this paper
• Pulmonary emphysema: objective quantification at multi-detector row CT--comparison with macroscopic and microscopic morphometry.

  2006cited by this paper
• C-reactive protein levels and clinically important predictive outcomes in stable COPD patients

  2006cited by this paper
• COPD, a multicomponent disease: implications for management.

  2005cited by this paper
• Bronchodilator response in the lung health study over 11 yrs

  2005cited by this paper
• Dissociation of lung function and airway inflammation in chronic obstructive pulmonary disease.

  2004cited by this paper
• The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease.

  2004cited by this paper
• Bronchodilator reversibility testing in chronic obstructive pulmonary disease

  2003cited by this paper
• Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease

  2002cited by this paper
• Elevated plasma fibrinogen associated with reduced pulmonary function and increased risk of chronic obstructive pulmonary disease.

  2001cited by this paper
• Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study.

  2001cited by this paper
• A randomized clinical trial of alpha(1)-antitrypsin augmentation therapy.

  1999cited by this paper
• Reversible and irreversible airflow obstruction as predictor of overall mortality in asthma and chronic obstructive pulmonary disease.

  1999cited by this paper
• Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study.

  1995cited by this paper
• Effects of Smoking Intervention and the Use of an Inhaled Anticholinergic Bronchodilator on the Rate of Decline of FEV1

  1994cited by this paper
• A "splitting" look at chronic nonspecific lung disease (CNSLD): common features but diverse pathogenesis.

  1991cited by this paper
• The natural history of chronic airflow obstruction.

  1977cited by this paper
• The Natural History of Chronic Bronchitis and Emphysema

  1977cited by this paper

• New approaches to uncover COPD pathobiology and develop therapies.

  2026cites this paper
• Relationship Between Phenotypical and Echocardiographic Findings With Pulmonary Hypertension in COPD Patients

  2025cites this paper
• Predicting the frequent exacerbator phenotype in COPD: development and validation of a multicenter real-world prediction model

  2025cites this paper
• Characteristics Associated with Lung Function Trajectories: An Analysis of the SPIROMICS Cohort.

  2025cites this paper
• Quantitative accuracy of lung function measurement using parametric response mapping: a virtual imaging study

  2024cites this paper
• Contrasting the clinical and biological characteristics of young and old COPD patients

  2024influential citation
• Sex Matters: A Deep Dive into Sex Differences in Chronic Obstructive Pulmonary Disease

  2024cites this paper
• Combined Lifestyle Interventions in the Prevention and Management of Asthma and COPD: A Systematic Review

  2024cites this paper
• Lung Function Impairment, Associating Hyperinflation with Impaired Diffusion Capacity and Transfer Coefficient, Is a Risk Factor for Hip Osteoporosis in Patients with Chronic Obstructive Pulmonary Disease

  2023cites this paper
• Epilogue to contemporary perspectives in COPD: New Horizons

  2021cites this paper
• NOVELTY: a landmark study in phenotyping and endotyping chronic obstructive airway diseases in real clinical practice

  2021cites this paper
• Chronic Obstructive Pulmonary Disease: Epidemiology, Biomarkers, and Paving the Way to Lung Cancer

  2021cites this paper
• Fibrinogen: A Feasible Biomarker in Identifying the Severity and Acute Exacerbation of Chronic Obstructive Pulmonary Disease

  2021cites this paper
• Statins as adjunct therapy in COPD: is it time to target innate immunity and cardiovascular risk?

  2021cites this paper
• Digital Health for Enhanced Understanding and Management of Chronic Conditions: COPD as a Use Case

  2021cites this paper
• Pulmonary function testing in COPD: looking beyond the curtain of FEV1

  2021cites this paper
• Development and Validation of a Method to Estimate COPD Severity in Multiple Datasets: A Retrospective Study

  2020cites this paper
• Decreased COPD prevalence in Sweden after decades of decrease in smoking

  2020cites this paper
• Bone mineral density in emphysema and chronic bronchitis phenotypes in hospitalized male chronic obstructive pulmonary disease patients

  2020cites this paper
• NEUTROPHIL TO LYMPHOCYTE RATIO AS A MARKER OF ACUTE EXACERBATION AND DISEASE SEVERITY IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE

  2020cites this paper
• Comparative analysis of pathophysiological parameters between emphysematous smokers and emphysematous patients with COPD

  2020cites this paper
• Characterisation of gas exchange in COPD with dissolved-phase hyperpolarised xenon-129 MRI

  2020cites this paper
• Frequency of Blood Eosinophilia in newly diagnosed Chronic Obstructive Pulmonary Disease patients

  2020cites this paper
• Radiological feature of chest x-ray in chronic obstructive pulmonary disease correlation with clinical finding

  2020cites this paper
• Machine Learning Algorithms Utilizing Functional Respiratory Imaging May Predict COPD Exacerbations.

  2019cites this paper
• Physical Activity Is Associated with Attenuated Disease Progression in Chronic Obstructive Pulmonary Disease

  2019cites this paper
• Spirometric indices of early airflow impairment in individuals at risk of developing COPD: Spirometry beyond FEV1/FVC.

  2019cites this paper
• Evaluation Of HHIP Polymorphisms And Their Relationship With Chronic Obstructive Pulmonary Disease Phenotypes

  2019influential citation
• Trends over time in COPD treatment choices by respiratory physicians: An analysis from the COLIBRI-COPD French cohort.

  2019cites this paper
• Machine Learning Algorithms Utilizing Functional Respiratory Imaging May Predict COPD Exacerbations.

  2019cites this paper
• Prospective observational study in patients with obstructive lung disease: NOVELTY design

  2019cites this paper
• Chronic obstructive pulmonary disease upper airway microbiota alpha diversity is associated with exacerbation phenotype: a case-control observational study

  2019cites this paper
• Real-world use of rescue inhaler sensors, electronic symptom questionnaires and physical activity monitors in COPD

  2019cites this paper
• Evaluation Of HHIP Polymorphisms And Their Relationship With Chronic Obstructive Pulmonary Disease Phenotypes

  2019influential citation
• Chronic Bronchitis: Where Are We Now?

  2019cites this paper
• Kronik Obstrüktif Akciğer Hastalığında Trakeobronşiyal Değişikliklerin Bilgisayarlı Tomografi ile Değerlendirilmesi

  2019cites this paper
• Genetics, Chronic Obstructive Pulmonary Disease, and the Arrow of Time

  2019cites this paper
• Evaluation Of HHIP Polymorphisms And Their Relationship With Chronic Obstructive Pulmonary Disease Phenotypes

  2019influential citation
• Prediction of first acute exacerbation using COPD subtypes identified by cluster analysis

  2019influential citation
• Probing Changes in Lung Physiology in COPD Using CT, Perfusion MRI, and Hyperpolarized Xenon-129 MRI.

  2019cites this paper
• Characterization of the “Frequent Exacerbator Phenotype” in Bronchiectasis

  2018cites this paper
• A Systems Medicine approach to multimorbidity. Towards personalised care for patients with Chronic Obstructive Pulmonary Disease

  2018cites this paper
• Relevance of the GOLD 2017 recommendations in habitual clinical practice.

  2018cites this paper
• Stable‐State Midrange Proadrenomedullin Is Associated With Severe Exacerbations in COPD

  2018cites this paper
• Physical Activity Is Associated with Attenuated Disease Progression in COPD

  2018cites this paper
• Evaluation of the COPDnet integrated care model in patients with COPD: the study protocol

  2018cites this paper
• Edinburgh Explorer Diagnosis, assessment and phenotyping of COPD: beyond FEV1

  2018cites this paper
• Arterial stiffness in adults with steady-state bronchiectasis: association with clinical indices and disease severity

  2018influential citation
• Surfactant Protein D in Respiratory and Non-Respiratory Diseases

  2018cites this paper
• Systemic vascular dysfunction is associated with emphysema burden in mild COPD.

  2018cites this paper
• Inflammation, coagulation and their interaction in Chronic Obstructive Pulmonary Disease

  2018influential citation
• Integration of multi-omics datasets enables molecular classification of COPD

  2018cites this paper
• Pulmonary quantitative CT imaging in focal and diffuse disease: current research and clinical applications.

  2018cites this paper
• Neutrophil to lymphocyte ratio and clinical outcomes in COPD: recent evidence and future perspectives

  2018cites this paper
• Evaluation of the COPDnet integrated care model in patients with COPD: the study protocol

  2018cites this paper
• Distribution, temporal stability and association with all-cause mortality of the 2017 GOLD groups in the ECLIPSE cohort.

  2018cites this paper
• Factors Associated With Progression of Lung Function Abnormalities in HIV-Infected Individuals

  2018cites this paper
• Acute flares of knee osteoarthritis in primary care: a feasibility and pilot case-crossover study

  2018cites this paper
• Health Status in Patients with COPD According to GOLD 2017 Classification: Use of the COMCOLD Score in Routine Clinical Practice

  2018cites this paper
• Fibrinogen as a potential biomarker for clinical phenotype in patients with chronic obstructive pulmonary disease.

  2018cites this paper
• C-reactive protein level predicts mortality in COPD: a systematic review and meta-analysis

  2017cites this paper
• Determinants of exacerbation risk in patients with COPD in the TIOSPIR study

  2017cites this paper
• Chronic Respiratory Symptoms with Normal Spirometry. A Reliable Clinical Entity?

  2017cites this paper
• After asthma: redefining airways diseases.

  2017cites this paper
• Multiple biomarkers predict disease severity, progression and mortality in COPD

  2017influential citation
• Relationship between FEV1 and arterial stiffness in elderly people with chronic obstructive pulmonary disease

  2017cites this paper
• The association between risk of airflow limitation and serum uric acid measured at medical health check-ups

  2017cites this paper
• Nintedanib nutzt auch bei erhaltenem Lungenvolumen

  2017cites this paper
• Examining the Effects of Age on Health Outcomes of Chronic Obstructive Pulmonary Disease: Results From the Genetic Epidemiology of Chronic Obstructive Pulmonary Disease Study and Evaluation of Chronic Obstructive Pulmonary Disease Longitudinally to Identify Predictive Surrogate Endpoints Cohorts.

  2017cites this paper
• Genetic mannose binding lectin deficiency is associated with airway microbiota diversity and reduced exacerbation frequency in COPD

  2017cites this paper
• Phenotypes of COPD patients with a smoking history in Central and Eastern Europe: the POPE Study

  2017cites this paper
• PDF hosted at the Radboud Repository of the Radboud University Nijmegen

  2017influential citation
• Serum Proteins Associated with Emphysema Progression in Severe Alpha-1 Antitrypsin Deficiency.

  2017cites this paper
• Cohort Study in COPD: Introduction to COPD Cohorts (The KOLD and COPDGene Study) and Collaborative Approaches

  2017cites this paper
• COPD: JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE

  2017cites this paper
• Impact of cataract on health-related quality of life in a longitudinal Japanese chronic obstructive pulmonary cohort

  2017influential citation
• Mid-regional pro-adrenomedullin and copeptin to predict short-term prognosis of COPD exacerbations: a multicenter prospective blinded study

  2017cites this paper
• Long-term treatment with budesonide/formoterol attenuates circulating CRP levels in chronic obstructive pulmonary disease patients of group D

  2017cites this paper
• After asthma – redefining airways diseases. A Lancet commission

  2017cites this paper
• Biomarkers of collagen turnover are related to annual change in FEV1 in patients with chronic obstructive pulmonary disease within the ECLIPSE study

  2017influential citation
• Phenotyping Before Starting Treatment in COPD?

  2017cites this paper
• The value of blood cytokines and chemokines in assessing COPD

  2017cites this paper
• Lung Mass in Smokers.

  2017cites this paper
• Clinical characteristics of chronic bronchitic, emphysematous and ACOS phenotypes in COPD patients with frequent exacerbations

  2017influential citation
• Faculty of Medicine University of Dhaka EFFECTIVENESS OF DIAPHRAGMATIC MANIPULATION ALONG WITH CONVENTIONAL PHYSIOTHERAPY FOR PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)

  2017cites this paper
• Biomarkers of extracellular matrix turnover are associated with emphysema and eosinophilic-bronchitis in COPD

  2017cites this paper
• Role of Proteases in Chronic Obstructive Pulmonary Disease

  2017cites this paper
• Alterations in Serum Polyunsaturated Fatty Acids and Eicosanoids in Patients with Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD)

  2016cites this paper
• Efficacy of inhaled medications in asthma and COPD related to disease severity

  2016cites this paper
• A phase III randomised controlled trial of single-dose triple therapy in COPD: the IMPACT protocol

  2016cites this paper
• Diagnosis, assessment, and phenotyping of COPD: beyond FEV1

  2016cites this paper
• A review of national guidelines for management of COPD in Europe

  2016cites this paper
• Assisted ventilation in COPD – association between previous hospitalizations and mortality

  2016cites this paper
• Translating Pharmacometrics to a Pharmacoeconomic Model of COPD.

  2016cites this paper
• Impaired Blood Neutrophil Function in the Frequent Exacerbator of Chronic Obstructive Pulmonary Disease: A Proof-of-Concept Study

  2016cites this paper
• Individualized lung function trends in alpha-1-antitrypsin deficiency: a need for patience in order to provide patient centered management?

  2016cites this paper
• Should the diagnosis of COPD be based on a single spirometry test?

  2016cites this paper
• Predictors of Hospitalized Exacerbations and Mortality in Chronic Obstructive Pulmonary Disease

  2016cites this paper
• Does Protease-Antiprotease Imbalance Explain Chronic Obstructive Pulmonary Disease?

  2016cites this paper
• The Neutrophil to Lymphocyte Ratio Is Related to Disease Severity and Exacerbation in Patients with Chronic Obstructive Pulmonary Disease.

  2016cites this paper